| An intra-tumoral niche maintains and differentiates stem-like CD8 T cells CS Jansen, N Prokhnevska, VA Master, MG Sanda, JW Carlisle, MA Bilen, ... Nature 576 (7787), 465-470, 2019 | 590 | 2019 |
| Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology CG Ethun, MA Bilen, AB Jani, SK Maithel, K Ogan, VA Master CA: a cancer journal for clinicians 67 (5), 362-377, 2017 | 476 | 2017 |
| Active surveillance for the management of prostate cancer in a contemporary cohort MA Dall'Era, BR Konety, JE Cowan, K Shinohara, F Stauf, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 462 | 2008 |
| Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma DM Schuster, JR Votaw, PT Nieh, W Yu, JA Nye, V Master, FDB Bowman, ... Journal of Nuclear Medicine 48 (1), 56-63, 2007 | 349 | 2007 |
| Too frail for surgery? Initial results of a large multidisciplinary prospective study examining preoperative variables predictive of poor surgical outcomes LM Revenig, DJ Canter, MD Taylor, C Tai, JF Sweeney, JM Sarmiento, ... Journal of the American College of Surgeons 217 (4), 665-670. e1, 2013 | 313 | 2013 |
| Hyperspectral imaging and quantitative analysis for prostate cancer detection H Akbari, LV Halig, DM Schuster, A Osunkoya, V Master, PT Nieh, ... Journal of biomedical optics 17 (7), 076005-076005, 2012 | 294 | 2012 |
| Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial M Gross-Goupil, TG Kwon, M Eto, D Ye, H Miyake, SI Seo, SS Byun, ... Annals of Oncology 29 (12), 2371-2378, 2018 | 233 | 2018 |
| Minimally invasive endovascular techniques to treat acute renal hemorrhage BN Breyer, JW McAninch, SP Elliott, VA Master The Journal of urology 179 (6), 2248-2253, 2008 | 218 | 2008 |
| Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010 SC King, LA Pollack, J Li, JB King, VA Master The Journal of urology 191 (6), 1665-1670, 2014 | 207 | 2014 |
| Anti-3-[18F]FACBC Positron Emission Tomography-Computerized Tomography and 111In-Capromab Pendetide Single Photon Emission Computerized … DM Schuster, PT Nieh, AB Jani, R Amzat, FDB Bowman, RK Halkar, ... The Journal of urology 191 (5), 1446-1453, 2014 | 206 | 2014 |
| Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC … A Amin, AZ Dudek, TF Logan, RS Lance, JM Holzbeierlein, JJ Knox, ... Journal for immunotherapy of cancer 3, 1-13, 2015 | 203 | 2015 |
| Detection of Recurrent Prostate Carcinoma with anti-1-Amino-3-18F-Fluorocyclobutane-1-Carboxylic Acid PET/CT and 111In–Capromab Pendetide SPECT/CT DM Schuster, B Savir-Baruch, PT Nieh, VA Master, RK Halkar, PJ Rossi, ... Radiology 259 (3), 852-861, 2011 | 174 | 2011 |
| Testicular tumors: what radiologists need to know—differential diagnosis, staging, and management C Coursey Moreno, WC Small, JC Camacho, V Master, N Kokabi, ... Radiographics 35 (2), 400-415, 2015 | 162 | 2015 |
| Recurrent prostate cancer detection with anti-3-[18F]FACBC PET/CT: comparison with CT OA Odewole, FI Tade, PT Nieh, B Savir-Baruch, AB Jani, VA Master, ... European journal of nuclear medicine and molecular imaging 43, 1773-1783, 2016 | 156 | 2016 |
| Penetrating external genital trauma: a 30-year single institution experience S Phonsombat, VA Master, JW McAninch The Journal of urology 180 (1), 192-196, 2008 | 155 | 2008 |
| Recent trends in prostate cancer incidence by age, cancer stage, and grade, the United States, 2001–2007 J Li, JA Djenaba, A Soman, SH Rim, VA Master Prostate cancer 2012, 2012 | 143 | 2012 |
| Management of severe urethral complications of prostate cancer therapy SP Elliott, JW McAninch, T Chi, SM Doyle, VA Master The Journal of urology 176 (6), 2508-2513, 2006 | 138 | 2006 |
| Ejaculatory physiology and dysfunction VA Master, PJ Turek Urologic Clinics of North America 28 (2), 363-376, 2001 | 131 | 2001 |
| The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced‐stage cancer treated with immunotherapy MA Bilen, DJ Martini, Y Liu, C Lewis, HH Collins, JM Shabto, M Akce, ... Cancer 125 (1), 127-134, 2019 | 129 | 2019 |
| Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double … SK Pal, R Uzzo, JA Karam, VA Master, F Donskov, C Suarez, L Albiges, ... The Lancet 400 (10358), 1103-1116, 2022 | 128 | 2022 |
Mehmet Asim BilenWinship Cancer Institute of Emory UniversityBestätigte E-Mail-Adresse bei emory.edu
